GlassScriptPhysician profile
Kimberly E Monday
NPI 1114908753
$7,062.66
in general payments reported to CMS, 2019-2025
53 companies · $1,421 in 2025
The $1,421 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,227 · 2020: $285 · 2021: $350 · 2022: $539 · 2023: $1,165 · 2024: $1,074 · 2025: $1,421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,549 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,548.85 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $914.95 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $580.85 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $446.94 | 2020-2025 | Austedo Xr, Austedo Xr |
| Alexion Pharmaceuticals, INC. | $374.08 | 2019-2025 | Ultomiris |
| Pfizer INC. | $346.61 | 2023-2025 | |
| Acorda Therapeutics, INC | $280.28 | 2019-2020 | |
| Abbott Laboratories | $272.13 | 2023-2025 | Infinity |
| Allergan, INC. | $263.49 | 2019-2021 | |
| Biogen, INC. | $251.16 | 2019-2025 | Vumerity, Tysabri, Spinraza |
| Octapharma USA, INC. | $249.33 | 2023 | Octagam Immune Globulin (Human) |
| Emd Serono, INC. | $248.30 | 2019-2025 | |
| Eisai INC. | $203.25 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $163.98 | 2019-2025 | Rexulti |
| Sk Life Science, INC. | $147.59 | 2022-2023 | |
| Adamas Pharmaceuticals, INC. | $135.99 | 2019 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Monday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.